• Should Doctors Invest in Facebook? Should Doctors Invest in Facebook? Investors often kick themselves for not having grabbed the opportunity to invest early in Microsoft or other companies that skyrocketed. Could Facebook be the same type of opportunity?
  • Only Hire Thin Doctors? Medscape Readers Fuel Fiery Debate Only Hire Thin Doctors? Medscape Readers Fuel Fiery Debate Should a hospital refuse to hire obese healthcare providers? A bioethicist's video on Medscape sparked agreement and outrage. Here's what your colleagues are saying.
  • What Would Healthcare Be Like Under 'President Romney'? What Would Healthcare Be Like Under 'President Romney'? The Presidential election is months away, but physicians, consumers, and politicians are speculating on changes Mitt Romney might make to our current healthcare system. Here are some possibilities.
  • Medscape's Best Places to Practice Medscape's Best Places to Practice Looking for a great place to practice medicine? You've got some terrific options. We analyzed physician density, malpractice coverage, insurance competition, medical board activity, insurance mix, income taxes, and cost of living in all 50 US states and the District of Columbia and come up with a list of the best -- and the worst -- states to practice in each region.
  • More Patients, More Revenue, but Less Rush. How? More Patients, More Revenue, but Less Rush. How? Doctors may think the only way to increase revenue is to add services, do more marketing, and change their practice. But there are ways to make more money by adapting what you're already doing. Here's how.
 

HIV/AIDS News
 – From Medscape Medical News, Reuters and more

  • U.S. HIV Aid Has Prevented 741,000 Deaths: Study U.S. HIV Aid Has Prevented 741,000 Deaths: Study The United States foreign aid program that sends billions of dollars to African countries for HIV treatment and prevention has cut the number of people dying for any reason in those nations.
  • FDA Panel Recommends First Drug for HIV Prevention FDA Panel Recommends First Drug for HIV Prevention The US Food and Drug Administration's Antiviral Drugs Advisory Committee has recommended approval of Gilead Science's Truvada for preexposure prevention of sexually acquired HIV-1 infection.
 

HIV/AIDS Perspectives

  • Eliminating Pediatric HIV Infection: Retention in PMTCT Eliminating Pediatric HIV Infection: Retention in PMTCT Eliminating pediatric HIV infection through the prevention of mother-to-child transmission care cascade will require new approaches to improving follow-up with both mothers and infants.
  • Hepatitis G Virus (GBV-C): What We Know So Far Hepatitis G Virus (GBV-C): What We Know So Far The hepatitis G virus, known as GBV-C, seems to be well tolerated and could be a silver lining for patients with HIV, yet it increases the risk for non-Hodgkin lymphoma.
 

Medscape Collaborations

 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.